Higher Bebington Health Centre, 25 Brackenwood Road, Bebington, Merseyside, CH63 2LR
Telephone: 0151 608 8889
We're open
Introducing ARTHROSAMID: An intra-articular polyacrylamide hydrogel (IPAAG)
We are excited to be one of only a select few clinics in the North West offering a new long acting treatment for knee pain caused by osteoarthritis. Arthrosamid® is a new type of treatment for knee osteoarthritis that offers patients an effective alternative to the currently available therapies. Based on an innovative non-biodegradable hydrogel technology, Arthrosamid® is 2.5% cross-linked polyacrylamide and 97.5% water. When injected into the knee Arthrosamid® cushions the joint and reduces pain, providing safe and sustained relief, all with one injection. It is a single-dose that provides long-acting pain relief usually exceeding 1-2 years without the need for surgery; the outcome is improved functionality of the knee, providing patients with sustained relief by reducing pain, stiffness and improving the quality of life for patients with knee osteoarthritis.
How does it work?
Arthrosamid® is an intra-articular polyacrylamide hydrogel injection (iPAAG) for the symptomatic treatment of knee osteoarthritis. Once injected into the inner joint cavity, it restores viscosity within the synovial fluid, improving lubrication and cushioning of the joint. Arthrosamid® also integrates into the synovium of the inner joint capsule creating a cushion-like effect. Injections are administered into the knee joint with ultrasound guidance giving you the assurance that it has been injected into exactly the correct location.
What are the benefits of Arthrosamid?
Simple
Arthrosamid® is injected into the intra-articular space as a minimally invasive, out-patient procedure. You do not need to stay in hospital for treatment and clinicians are very familiar with injections into the knee joint.
Safe
Arthrosamid® is safe for intended use and is biocompatible which allows it to integrate with the tissues in your knee. The overall safety profile of the hydrogel has undergone two decades over of research and development with approximately 1,000,000 hydrogel units used for various indications in the body.
Sustained
In clinical trials, patients reported a reduction in their pain levels by Week 4 after their injection. The reduction in pain was sustained over 3 years. Arthrosamid® trials will continue to follow patients for 5 years.
If you would like more information regarding how Arthosamid can help free you from arthritis pain then please click on the links below.
Arthrosamid-Patient-Brochure-2023
BOOK ONLINE (Select Skin and Joint Injection Clinic)
If you would like to enquire about any of the above treatments then please contact us by phone or via email or book online:
Phone: 0151 203 7840
Email : info@skinjointclinic.co.uk